Amiodarone-induced bone marrow granulomas: an unusual cause of reversible pancytopenia

Hematology Reports
|December 21, 2011
PubMed

Insights

Amiodarone can cause bone marrow granulomas, leading to pancytopenia. Discontinuing amiodarone therapy can reverse these blood count abnormalities over several months.

Area of Science:

  • Hematology
  • Pharmacology
  • Pathology

Background:

  • Bone marrow granulomas are uncommon and typically linked to infections, lymphomas, or sarcoidosis.
  • Drug-induced bone marrow granulomas are an underrecognized cause of hematologic abnormalities.
  • Amiodarone is a rare but documented cause of bone marrow granuloma formation.

Observation:

  • A 73-year-old male presented with pancytopenia during a preoperative assessment.
  • Diagnostic evaluation excluded other causes, leading to suspicion of amiodarone therapy.
  • Bone marrow biopsy revealed granulomas, consistent with amiodarone-induced pathology.

Findings:

  • Suspected amiodarone-induced bone marrow granuloma formation was identified as the cause of pancytopenia.
  • Cessation of amiodarone therapy resulted in the gradual resolution of pancytopenia.
  • Blood counts improved over several months following drug discontinuation.

Implications:

  • Highlights amiodarone as a potential cause of reversible pancytopenia.
  • Emphasizes the importance of considering drug etiologies for bone marrow granulomas.
  • Provides a clinical timeline for expected recovery after amiodarone cessation.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...